Third View Private Wealth
REGN icon

Third View Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Third View Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.98M Sell
7,892
-135
-2% -$102K 0.71% 28
2026
Q2 		$5.01M Buy
8,027
+250
+3% +$170K 0.61% 33
2026
Q1 		$6.01M Buy
7,777
+628
+9% +$481K 0.82% 25
2025
Q4 		$5.52M Buy
+7,149
New +$4.85M 0.74% 28

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Third View Private Wealth's REGN Position: Q3 2026 in Review

Third View Private Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q3 2026, selling an estimated $102K and leaving 7,892 shares worth $5.98M. The position accounts for 0.71% of the portfolio, ranked #28.

Third View Private Wealth first reported a position in REGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.01M in Q1 2026. 755 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Third View Private Wealth held 7,892 shares of Regeneron Pharmaceuticals worth $5.98M as of Q3 2026.
  • Third View Private Wealth sold 135 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $102K.
  • Regeneron Pharmaceuticals made up 0.71% of Third View Private Wealth's portfolio in Q3 2026, its #28 holding.
  • Third View Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Third View Private Wealth's Regeneron Pharmaceuticals position peaked at $6.01M in Q1 2026.
  • 755 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.